ArticleCancers2025

Real-World Treatment Outcomes of Different Sequencing Options with Daratumumab, Lenalidomide, and Dexamethasone in Patients with Transplant-Ineligible Multiple Myeloma in Japan.

Kazuhito Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.